The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Oncoceutics
Integrated clinical experience with ONC201 in H3 K27M glioma.
 
Andrew S. Chi
No Relationships to Disclose
 
Sharon L. Gardner
No Relationships to Disclose
 
Isabel Arrillaga
Honoraria - Merck
Consulting or Advisory Role - Insys Therapeutics; Karus Therapeutics
 
Patrick Y. Wen
Consulting or Advisory Role - AbbVie; Agios; AstraZeneca; Aurora Biopharma; Genentech/Roche; GW Pharmaceuticals; Immunomic Therapeutics; Kadmon; Karyopharm Therapeutics; Lilly; Monteris Medical; Vascular Biogenics; Vivus; ZIOPHARM Oncology
Speakers' Bureau - Merck
Research Funding - Abbvie (Inst); Agios (Inst); Angiochem (Inst); ARIAD (Inst); AstraZeneca (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); ImmunoCellular Therapeutics (Inst); Karyopharm Therapeutics (Inst); Lilly; Merck (Inst); Novartis (Inst); Oncoceutics (Inst); Sanofi (Inst); Vascular Biogenics (Inst)
 
Tracy Batchelor
Honoraria - Champions Biotechnology; Genomicare; Imedex; Merck; NXDC; UpToDate
Consulting or Advisory Role - Amgen; GenomiCare; Merck; NXDC
Travel, Accommodations, Expenses - Merck; Roche/Genentech
 
Matthew David Hall
No Relationships to Disclose
 
Yazmin Odia
No Relationships to Disclose
 
Wafik Tharwat Zaky
No Relationships to Disclose
 
Soumen Khatua
No Relationships to Disclose
 
Nicole A. Shonka
No Relationships to Disclose
 
Ziad Khatib
No Relationships to Disclose
 
Rohinton Tarapore
No Relationships to Disclose
 
Lee Schalop
Employment - Oncoceutics
Leadership - Oncoceutics
Stock and Other Ownership Interests - Oncoceutics
 
Joshua E. Allen
Employment - Oncoceutics
Leadership - Oncoceutics
Stock and Other Ownership Interests - Oncoceutics
 
Wolfgang Oster
Employment - Oncoceutics
Leadership - Oncoceutics
Stock and Other Ownership Interests - Oncoceutics
 
Minesh P. Mehta
Leadership - Oncoceutics
Stock and Other Ownership Interests - Pharmacyclics
Consulting or Advisory Role - Abbvie; Agenus; AstraZeneca; Celgene; IBA; Insys Therapeutics; Oncoceutics; Remedy Pharmaceuticals; Tocagen; Varian Medical Systems
Patents, Royalties, Other Intellectual Property - WARF patent 14/934,27, TOPICAL VASOCONSTRITOR PREPARATIONS AND METHODS FOR PROTECTING CELLS DURING CANCER CHEMOTHERAPY AND RADIOTHERAPY
Other Relationship - Monteris Medical